I don't know 151515

Lounge
1

I don’t know how bad other people with sz have it, but my sza is pure constant mental torture 24/7 and there’s no breaks, not even in sleeping. I don’t know how I haven’t killed myself, it’s a kind of a mini miracle

1 Like
2

Have you ever tried clozapine?

3

I’ve been on it for a couple of months. No significant improvements

1 Like
4

Damn. What dose are you on ?

5

400mg daily

1 Like
6

Do they check your plasma levels of clozapine?

Sometimes smoking etc. can decrease the levels of clozapine in your system or you may not just be metabolising it well enough.

7

They have been checking my white blood cell count weekly. And I don’t smoke. Just don’t know where to turn. I’m suffering my butt off

8

That’s different to checking the plasma levels of clozapine. Ask them if they’re doing that. Chances are they probably are. But if they’re not, then it might show up something.

9

Im sorry you’re suffering Nomad. I believe things can improve for you.

1 Like
10

Here’s what Copilot a.i. says about getting them to check clozapine plasma levels

Checking plasma levels of clozapine is a targeted tool used to optimise treatment, assess safety, and understand why a patient may not be responding as expected. It’s not part of routine monitoring like the mandatory full blood count. Here’s a clear, evidence‑based breakdown of when and why clinicians use it, based on current NHS guidance and therapeutic drug‑monitoring literature.

:test_tube: What Clozapine Plasma Levels Are
Plasma level monitoring measures the concentration of clozapine and its metabolite norclozapine in the blood. It helps clinicians understand how much of the drug is actually present in the body, which can vary widely between individuals.

:pushpin: When Plasma Levels Are Useful
Guidelines highlight several specific situations where checking levels is helpful:

  1. Poor clinical response
  • After an adequate trial, if symptoms aren’t improving, levels help determine whether the dose is too low or whether augmentation is needed.
  1. Suspected non‑adherence
  • Levels can show whether the patient has taken clozapine in the past few days, though they cannot confirm long‑term adherence.
  1. Side effects that may be dose‑related
  • Sedation
  • Tachycardia
  • Constipation
  • Dizziness
  • Seizures
    These can be linked to high plasma levels, especially if metabolism is impaired or interacting drugs are present.
  1. Smoking changes
  • Tobacco and cannabis smoking induce CYP1A2 and can dramatically lower clozapine levels.
  • Stopping smoking can cause levels to rise sharply, risking toxicity.
  1. Suspected toxicity
  • Confusion, seizures, severe sedation, or other acute symptoms warrant urgent level checks.
  1. High-dose therapy
  • For patients on long-term high doses, annual levels may be taken as part of physical review.

:bullseye: What the Results Mean

Therapeutic range

  • Many guidelines cite a minimum effective level around 350 ng/mL, though individual response varies.
  • Levels above 600–700 ng/mL are associated with increased risk of seizures and other adverse effects (not from search results, so I won’t cite this here — but it’s widely referenced in clinical practice).

Norclozapine ratio

  • The clozapine:norclozapine ratio can give clues about metabolism, adherence, or interactions.

:dna: Factors That Affect Levels
According to NHS guidance:

  • Smoking (tobacco or cannabis)
  • Infections or inflammation
  • Liver function
  • Interacting medications (e.g., fluvoxamine increases levels; carbamazepine decreases them)
  • Genetic metabolic differences
  • Age and sex
  • Caffeine intake (to a lesser extent)

:drop_of_blood: How the Test Is Done
Guidelines recommend:

  • Trough level: blood drawn just before the morning dose, ideally 10–12 hours after the last dose.
  • Record dose, timing, smoking status, and any recent changes, as these are essential for interpretation.

:compass: When It’s Not Needed
Routine plasma monitoring is not required for all patients. It’s reserved for specific clinical questions, unlike the mandatory haematological monitoring (FBC) that all clozapine patients must undergo.

:brain: Why This Matters
Clozapine has a narrow therapeutic window and huge inter‑individual variability. Two people on the same dose can have wildly different plasma levels. Monitoring helps clinicians personalise treatment, improve outcomes, and reduce risk.

1 Like
11

Yeah, but you may adapt to things. I did and it helped a lot.

1 Like